C1 esterase inhibitor and the contact system in COVID-19

Br J Haematol. 2020 Aug;190(4):520-524. doi: 10.1111/bjh.16938. Epub 2020 Jul 28.

Abstract

Coronavirus disease 2019 (COVID-19) is frequently associated with severe systemic consequences, including vasculitis, a hyperinflammatory state and hypercoagulation. The mechanisms leading to these life-threatening abnormalities are multifactorial. Based on the analysis of publicly available interactomes, we propose that severe acute respiratory syndrome coronavirus-2 infection directly causes a deficiency in C1 esterase inhibitor, a pathogen-specific mechanism that may help explain significant systemic abnormalities in patients with COVID-19.

Keywords: SARS-CoV-2; complement; contact system; serpins; virology.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • COVID-19 / metabolism*
  • COVID-19 / pathology
  • Complement C1 Inhibitor Protein / metabolism*
  • Humans
  • SARS-CoV-2 / metabolism*

Substances

  • Complement C1 Inhibitor Protein
  • SERPING1 protein, human